by European Public Health Alliance | Sep 7, 2016 | Reports
A new EPHA paper discusses the importance of the added value of European action on antimicrobial resistance (AMR) in relation to the Proposals for draft guidelines on the prudent use of antimicrobials in human medicine released by the European Centre for Disease...
by European Public Health Alliance | Aug 8, 2016 | Opinion
By Sascha Marchang, Policy Manager, EPHA A recent debate organised by thinktank Bruegel brought together policymakers, civil society and industry representatives to discuss the recommendations of the UK Review on AMR published in May 2016. The event ‘Tackling...
by European Public Health Alliance | Aug 8, 2016 | Opinion
By Sascha Marschang, Policy Manager, EPHA EPHA and Changing Markets unveils how the pharmaceutical industry’s role in contributing to the spread of antimicrobial resistance (AMR) via pollution of the environment in a new briefing. The failure to produce drugs...
by European Public Health Alliance | Jul 3, 2016 | Opinion
In June 2016, EPHA attended the Public Health 2016 conference in Toronto which, among many other topics, discussed antimicrobial resistance (AMR) in a satellite symposium. How can AMR be framed as an urgent public health issue that will engage the entire public...
by European Public Health Alliance | Jun 20, 2016 | Opinion
By Sascha Marschang, Policy Manager for Health Systems The Health Council Conclusions on the next steps to combat Antimicrobial Resistance, released on 17 June 2016, urge national governments and the European Commission to collaborate more effectively and coordinate...
